Skip to main content

Peripheral Vascular Devices: The Role of Regulatory Approvals and Market Expansion on Projected CAGR by 2030

The global peripheral vascular devices market is set to witness a growth rate of 6% in the next 5 years. Rising prevalence of peripheral vascular diseases (PVDs); technological advancements in peripheral vascular devices; increasing geriatric population; rising preference for minimally invasive procedures and increasing prevalence of lifestyle-related diseases are some of the key factors driving the peripheral vascular devices market.

Peripheral vascular devices are medical tools and implants used to diagnose and treat conditions affecting the peripheral vascular system, which includes blood vessels outside the heart and brain. These devices address diseases such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency. Common types include stents, angioplasty balloons, catheters, atherectomy devices, and vascular grafts. They are primarily utilized in minimally invasive procedures to restore blood flow, remove blockages, and manage vascular abnormalities. With advancements in technology, these devices enhance patient outcomes by reducing procedure-related risks and recovery times, making them essential in modern vascular care.

🔗 Want deeper insights? Download the sample report here: https://meditechinsights.com/peripheral-vascular-devices-market/request-sample/ 

Rising prevalence of peripheral vascular diseases (PVDs) to propel market demand

The rising prevalence of peripheral vascular diseases (PVDs), such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency, is a significant driver for the peripheral vascular devices market. As of 2023, PAD was present in over 12 million people in the US and 200 million individuals worldwide (Source: American Heart Association).  Aging populations, increasing rates of diabetes, obesity, and smoking, and sedentary lifestyles are key factors contributing to the growing incidence of PVDs. These conditions often require interventional treatments to restore blood flow and prevent complications like amputations or life-threatening clots. As a result, the demand for advanced devices like stents, catheters, and angioplasty balloons has surged, fueling innovation and growth in the peripheral vascular devices market

Technological advancements in peripheral vascular devices are driving the market growth

Technological advancements in peripheral vascular devices are fueling market growth by enhancing treatment effectiveness and patient safety. Innovations such as drug-eluting stents, bioresorbable vascular scaffolds, and advanced balloon catheters offer improved outcomes by reducing restenosis and enhancing blood flow restoration. Devices incorporating imaging technologies like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) enable precise diagnosis and intervention. Minimally invasive tools, such as hybrid stents and directional atherectomy devices, reduce procedure-related risks and recovery times. These advancements drive demand by improving procedural success rates and expanding the range of treatable peripheral vascular conditions.

Competitive Landscape Analysis

The global peripheral vascular devices market is marked by the presence of established and emerging market players such as Abbott, Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company, Terumo Corporation, B. Braun SE, Teleflex Incorporated, W. L. Gore & Associates, Inc., and Cordis; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get PDF Report for Competitive Analysis: 

https://meditechinsights.com/peripheral-vascular-devices-market/request-sample/ 

Global Peripheral Vascular Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global peripheral vascular devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, and end user.

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Peripheral Stents
      • Iliac Artery Stents
      • Femoral Artery Stents
      • Carotid Artery Stents
      • Renal Artery Stents
      • Other Peripheral Stents
    • Angioplasty Balloons
      • Old/Normal Balloons
      • Drug-Eluting Balloons
      • Cutting & Scoring Balloons
    • Catheters
      • Angiography Catheters
      • Guiding Catheters
      • IVUS/OCT Catheters
    • Endovascular Aneurysm Repair Stent Grafts
      • Thoracic Endovascular Aneurysm Stent Grafts
      • Abdominal Endovascular Aneurysm Stent Grafts
      • Plaque Modification Devices
      • Atherectomy Devices
      • Thrombectomy Devices
    • Inferior Vena Cava Filters
      • Permanent Filters
      • Retrievable Filters
    • Hemodynamic Flow Alteration Devices
      • Chronic Total Occlusion Devices
      • Embolic Protection Devices
    • Peripheral Accessories
      • Guidewires
        • Workhorse Guidewires
        • Specialty Guidewires
        • Extra Support Guidewires
        • Frontline Finesse Guidewires
      • Peripheral Vascular Closure Devices
      • Balloon Inflation Devices
      • Introducer Sheaths
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • Medical and Pharmaceutical Applications
    • Peripheral Artery Disease (PAD)
    • Deep Vein Thrombosis (DVT)
    • Aneurysms
    • Chronic Venous Insufficiency
    • Others
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Specialty Clinics
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

 

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com 

Comments

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...